Mason Freeman serves as Executive at CinCor Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Mason Freeman has executed 7 insider transactions totaling $41.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 24, 2023 involved selling 40,000 shares valued at $0.
Mason Freeman currently holds 40,000 shares of CinCor Pharma, Inc. (CINC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mason Freeman has been a net buyer of CINC stock. They have purchased $41.6K and sold $91 worth of shares.
Mason Freeman's most recent insider trade was on Feb 24, 2023, when they sold 40,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 24, 2023 | CINC | $0 | Tender | 2,494 | $N/A | Discretionary |
| Jan 26, 2023 | CINC | $0 | Award | 40,000 | $N/A | Discretionary |
| Jun 10, 2022 | CINC | $91 | Sale | 6 | $15.21 | Discretionary |
| Jan 11, 2022 | CINC | $40.0K | Purchase | 2,500 | $16.00 | Discretionary |
| Jan 11, 2022 | CINC | $1.6K | Purchase | 100 | $16.00 | Discretionary |